Aspirin study for people with stable heart artery disease
Treatments studied
Part of Heart & circulation, Pain clinical trials.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stable coronary artery disease (chronic coronary syndrome) with at least 50% blockage in a heart artery found on CT scan or angiography
- Your doctor says you are not eligible for revascularization procedures (like stents or bypass surgery)
- You can sign informed consent to join the study
- You have NOT had a recent heart attack or other acute coronary syndrome
- You have NOT previously had stent placement (PCI) or bypass surgery (CABG)
- You can take aspirin safely as part of the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking aspirin can help people who have early signs of coronary artery disease (buildup in heart arteries) but have never had a heart attack or stroke. The goal is to see if aspirin prevents future heart problems in these patients.
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
This study compares two different daily doses of aspirin (50 mg vs 100 mg) when taken with a standard blood thinner (P2Y12 inhibitor) after getting a heart stent. It aims to see if a lower aspirin dose works just as well with fewer side effects.
This study tests if different types of aspirin (coated or chewable) and a special schedule can help people with heart or blood vessel disease when they are exposed to air pollution. If you live in Tehran and have stable heart disease, you may be able to join.
This trial compares two common “blood thinner” combinations to prevent problems after a PCI procedure for complex blocked heart arteries. It may help your care team find which combination works better for people with higher-risk artery patterns.
This trial tests whether clopidogrel (a blood-thinning medicine) can prevent future heart attacks or strokes in people who have early, “subclinical” plaque in their heart arteries. You may be considered if scans show plaque but not major artery blockage that needs a procedure.
Hear when a new Stable Angina Pectoris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.